Objectives: Advancement in technology has led to a decrease in invasiveness for surgical management of malignant renal neoplasms. Laparoscopic radical nephrectomy is an established treatment for renal tumors. Since the introduction of robotic surgery in the realm of urology, many procedures have been done robotically. We evaluated the feasibility, safety, and oncological outcomes of robotic radical nephrectomy (RRN). Methods: We retrospectively reviewed the records of patients who underwent RRN for renal tumors at our institute from September 2007 to March 2011. Patients with standard indications for a radical nephrectomy were offered a robot-assisted procedure. Intraoperative parameters (operative time, blood loss, transfusion of blood products), postoperative parameters and complications were recorded. Results: Twenty-three patients who underwent RRN were included. Mean operative time was 132.7 min and mean blood loss 270 ml. The majority of patients were able to tolerate liquid diet, were free from drain, and were fit for discharge by postoperative day (POD) 1, POD 2 and POD 3, respectively. After the mean follow-up of 29.4 months, no patient had residual tumor, local recurrence or metastasis. Conclusion: We conclude that RRN is a feasible and safe procedure with good oncological outcome on short-term follow-up.

Keywords:
Robotic radical nephrectomy, Laparoscopic radical nephrectomy, Renal cell carcinoma
1.
Campbell SC, Novick AC, Bukowski RM: Urothelial tumors of the upper urinary tract; in Wein AJ (ed): Campbell-Walsh Urology, ed 9. Philadelphia, Saunders Elsevier, 2007, pp 1600–1601.
2.
Dasgupta P, Kirby RS: The current status of robot-assisted radical prostatectomy. Asian J Androl 2009;11:90–93.
3.
Kaul S, Menon M: Robotics in laparoscopic urology. Minim Invasive Ther Allied Technol 2005;14:62–70.
4.
Murphy D, Challacombe B, Olsburgh J, et al: Ablative and reconstructive robotic-assisted laparoscopic renal surgery. Int J Clin Pract 2008;62:1703–1708.
5.
Hemal AK, Menon M: Robotics in urology. Curr Opin Urol 2004;14:89–93.
6.
Guru KA, Hussain A, Chandrasekhar R, et al: Current status of robot-assisted surgery in urology: a multi-national survey of 297 urologic surgeons. Can J Urol 2009;16:4736–4741.
7.
Klingler DW, Hemstreet GP, Balaji KC: Feasibility of robotic radical nephrectomy – initial results of single institution pilot study. Urology 2005;65:1086–1089.
8.
Horgan S, Vanuno D, Sileri P, Cicalese L, et al: Robotic-assisted laparoscopic donor nephrectomy for kidney transplantation. Transplantation 2002;73:1474–1479.
9.
Guillonneau B, Jayet C, Tewari A, et al: Robot assisted laparoscopic nephrectomy. J Urol 2001;166:200–201.
10.
Nazemi T, Galich A, Sterrett S, et al: Radical nephrectomy performed by open, laparoscopy with or without hand-assistance or robotic methods by the same surgeon produces comparable perioperative results. Int Braz J Urol 2006;32:15–22.
11.
Rogers C, Laungani R, Krane LS, et al: Robotic nephrectomy for the treatment of benign and malignant disease. BJU Int 2008;102:1660–1665.
12.
Hemal AK, Kumar A: A prospective comparison of laparoscopic and robotic radical nephrectomy for T1–2N0M0 renal cell carcinoma. World J Urol 2009;27:89–94.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.